gototopgototop
PAION AG
Key Visual paion.de

Newsroom 2007

  • Ad hoc: PAION expands agreement with Lundbeck for Desmoteplase
  • Press release: PAION is seeking a new US-partner for Desmoteplase
  • Press release: PAION AG announces results for Q3 and first 9 months /2007
  • Press release: PAION reports successful start of Phase I study with anticoagulant Solulin
  • Press release: PAION sees continued development rationale for Desmoteplase based on findings from Phase III analysis
  • Ad hoc: PAION's partner Forest terminates co-development on Desmoteplase
  • Press release: PAION reports results for the first half-year 2007
  • Ad hoc: PAION reduces number of employees
  • Press release: Annual general meeting elects Dr. Jörg Spiekerkötter to the supervisory board
  • Ad hoc & press release: Topline results of Phase III study in acute ischemic stroke (DIAS-2) do not demonstrate difference between desmoteplase and placebo
  • Press release: PAION AG announces results for Q1/2007
  • Press release: PAION AG announces change in the supervisory board
  • Press release: PAION AG publishes annual results for 2006